KPV

Preclinical — cells or animals

Research-only / investigational — not FDA approved

Investigational; no FDA-approved drug label is established for this entry. Source: FDA: safety concerns for nominated peptide substances

What it is

A peptide studied in intestinal and immune cells and mouse models. Source: Cell and mouse study: KPV and intestinal inflammation

What it has been studied for

Intestinal inflammation in preclinical models. Source: Cell and mouse study: KPV and intestinal inflammation

Mechanism

Cell uptake through the PepT1 transporter was associated with reduced inflammatory signaling. Source: Cell and mouse study: KPV and intestinal inflammation

KPVCell uptake through the PepT1 transporter was associated with reduced inflammatory signaling.Evidence context: Preclinical — cells or animals

Documented dosing

No applicable general-use human dose range, frequency or cycle is documented here. Numbers from other routes, formulations or conditions are not interchangeable.

Open the calculator for KPV

Pairings & cautions

No evidence-based peptide pairing is specified in this entry.

FDA identifies unresolved safety concerns for this substance. Source: FDA: safety concerns for nominated peptide substances

These are selected considerations, not a complete safety review. Discuss the full source and your medications with your prescriber.

Sources

Explore care at The Health Institute